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Abstract
Background: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal illness whose pathogenesis remains poorly
understood. Recent evidence suggests oxidative stress as a key player in the establishment/progression of lung fibrosis in
animal models and possibly in human IPF. The aim of the present study was to characterize the cellular phenotype of
fibroblasts derived from IPF patients and identify underlying molecular mechanisms.
Methodology/Principal Findings: We first analyzed the baseline differentiation features and growth ability of primary lung
fibroblasts derived from 7 histology proven IPF patients and 4 control subjects at different culture passages. Then, we
focused on the redox state and related molecular pathways of IPF fibroblasts and investigated the impact of oxidative stress
in the establishment of the IPF phenotype. IPF fibroblasts were differentiated into alpha-smooth muscle actin (SMA)-positive
myofibroblasts, displayed a pro-fibrotic phenotype as expressing type-I collagen, and proliferated lower than controls cells.
The IPF phenotype was inducible upon oxidative stress in control cells and was sensitive to ROS scavenging. IPF fibroblasts
also contained large excess of reactive oxygen species (ROS) due to the activation of an NADPH oxidase-like system,
displayed higher levels of tyrosine phosphorylated proteins and were more resistant to oxidative-stress induced cell death.
Interestingly, the IPF traits disappeared with time in culture, indicating a transient effect of the initial trigger.
Conclusions/Significance: Robust expression of a-SMA and type-I collagen, high and uniformly-distributed ROS levels,
resistance to oxidative-stress induced cell death and constitutive activation of tyrosine kinase(s) signalling are distinctive
features of the IPF phenotype. We suggest that this phenotype can be used as a model to identify the initial trigger of IPF.
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Introduction
Idiopathic pulmonary fibrosis (IPF) is a progressive and lethal
lung disorder with a mean survival of 3–6 years from the onset of
symptoms. Histology of IPF shows the features of usual interstitial
pneumonia with patchy distribution of fibrosis adjacent to
fibroblastic foci (FF) [1]. IPF appears to be an ‘‘epithelial-
fibroblastic disease’’ resulting from recurrent epithelial injury and
abnormal wound repair [2]. FF are composed of migrating and
proliferating fibroblasts and of differentiated myofibroblasts
accounting for extra-cellular matrix deposition slowly altering
the alveolus structure. This explains the progressive and
irreversible IPF nature and the prognostic value of the fibrosis
extent [3,5].
IPF pathogenesis is unknown and the role of inflammation
remains controversial, since anti-inflammatory treatment does not
produce significant benefit against the disease progression.
Inflammation is likely the triggering event for the initiation of
fibrosis; eventually, fibrosis self-maintains and progresses by an
unknown process [6,7]. Recent studies have emphasized the role
of oxidative stress as the molecular basis of lung fibrosis. Reactive
oxygen species (ROS) are key players in the establishment/
progression of pulmonary fibrosis in animal models and possibly in
human IPF [8–11]. There is evidence of disruption of the normal
oxidant/antioxidant balance in the lungs of IPF patients.
Deficiency of antioxidants, including glutathione and superoxide
dismutase, has been found in the lower respiratory tract of IPF
patients, while high levels of myeloperoxidase are associated with
epithelial injury in the fibrotic lesions [12–14].
Fibroblasts and myofibroblasts are recognized as the effector
cells in normal wound healing and in the development of tissue
fibrosis [15]. Although the interaction of these cells with a large
PLoS ONE | www.plosone.org 1 November 2010 | Volume 5 | Issue 11 | e14003spectrum of growth factors involved in tissue remodelling has been
extensively investigated in IPF, their relationship with oxidative
stress remains poorly clarified. The aim of the present study was to
characterize the baseline cellular phenotype of fibroblasts derived
from IPF patients and to identify molecular targets underlying this
phenotype.
Materials and Methods
Ethics Statement
The study was approved by the Institutional Review Board for
biomedical activities of the Universities of Naples, Ancona and
Catania and by the Ethics Committee of the Monaldi hospital,
Naples, all in Italy. Patients provided written informed consent.
Cell culture
Primary lines of human lung fibroblasts were established by
using an outgrowth from explant following the method described
by Jordana et al. [16]. IPF cell lines were obtained from 7 patients
affected by IPF (age range 48–60 y), undergoing surgical lung
biopsy for diagnosis. Control fibroblasts were derived from normal
lung tissue of 4 patients with tumour-free areas of lung lobes with
early stage bronchial carcinoma (age range 45–55 y). Cells were
grown under standard conditions at 37uCi n5 %C O 2 in DMEM
with 1 g/l glucose supplemented with 10% fetal bovine serum
(FBS), 2 mM L-glutamine, 100 IU/ml penicillin and 100 mg/ml
streptomycin, and used at 80–90% confluence at different culture
passages. To distinguish experiments with different culture timing,
cells used within passage VI were arbitrary referred as ‘‘early
passage’’ while cells used later on through passages IX-XI were
referred as ‘‘late passage’’. Overall, early passage cells were defined
as cells within 20–25 population doublings (PD), while late passage
cells had a PD greater than 45. All reagents were purchased from
GIBCO (Scotland, UK). All experiments were performed in
duplicate.
Cell treatments
Reagents used for cell treatments included: 1. H2O2 (Sigma, St.
Louis, MO, USA); 2. the recombinant human transforming
growth factor (rhTGF)-b1 (Calbiochem, Merck Darmstadt,
Germany); 3. the TGF-b receptor ALK5 inhibitor SB-431542
(Sigma); 4. the ROS scavenger, N-acetylcisteine (NAC, Sigma);
and 5. the general oxidase inhibitor diphenyleneiodonium (DPI,
Calbiochem). Additional treatments included the MEK kinase
inhibitor UO126 and the receptor tyrosine kinase (RTKs)
inhibitors AG1296 (PDGF-R inhibitor) and AG1478 (EGF-R
inhibitor) (Calbiochem) [17]. Dose-response curves were per-
formed with all reagents.
Cell proliferation assay
Proliferation assays were performed in 96-well microtiter plates.
Cells were cultured at a density of 1610
3 viable cells per well for
48 h and pulsed for additional 24 h with 0.25 mCi/well of [
3H]
thymidine (Amersham, Pharmacia Biotech Buckinghamshire,
UK). Cells were harvested on glass-fiber filters using a Tomtec
(Orange) 96-well cell harvester and counted in a 1205 Betaplate
liquid scintillation counter (Wallac). Results obtained from three
wells were expressed as mean cpm6SD.
Cell death assay
Non adherent and trypsin-treated adherent cells were collected
and washed twice with cold PBS. Cell pellets were re-suspended in
1 ml of propidium iodide (PI) staining solution (PI 5 mg/ml).
Samples were kept at room temperature (RT) in the dark and
immediately analysed by flow cytometry (Cyan DAKO Cytoma-
tion, Colorado, USA). For each sample 30.000 events were
acquired and PI positive cells were detected at a wavelength of
635 nm. Data analysis was carried out with the Summit software
(version 4.3, DAKO).
Senescence b-galactosidase assay
Medium was removed from sub-confluent cultures. Cells were
fixed with 3% formaldehyde for 10 min at RT, washed and
incubated overnight at 37uC in staining solution containing 1 mg/
ml X-Gal (5-bromo-4-chloro-3-indolyl-b-D-galactopyranoside),
purchased from Promega (Madison, WI, USA), 40 mM citric
acid/sodium phosphate (pH 6.0), 5 mM potassium ferrocyanide,
5 mM potassium ferricyanide, 150 mM NaCl, and 2 mM MgCl2.
Cells were checked under a microscope for development of blue
colour and the mean percentage of b-galactosidase-positive cells
was calculated by counting 3 representative fields.
RNA purification and real-time PCR
Total RNA was extracted with TRIzol reagent according to the
manufacturer’s protocol (Sigma) and two micrograms were
reverse-transcribed with the Omniscript RT kit (Qiagen, Milan,
Italy) using random primers (1 mM) at 37uC for 1 h. Real time
PCR was performed in triplicate in 20 ml reaction volumes using
the Power SYBER Green PCR Master Mix (Applied Biosystems,
Foster City, CA, USA). PCR primers (0.2 mM) for human A2
type-I collagen used were: sense 59-TCTGGAGAGGCTGG-
TACTGC-39 and anti-sense 59-GAGCACCAAGAAGACCCT-
GA-39. PCR primers (2 mM) for human transforming growth
factor (TGF)-b used were: sense 59-ACTACTACGCCAAGG-
AGGTCAC-39, anti sense 59- TGCTTGAACTTGTCATAGA-
TTTCG-39. 18S RNA was used as reference (sense 59-TCC CCA
TGA ACG AGG AAT TC-39 and anti-sense 59-GTG TAC AAA
GGG CAG GGA CTT-39). All primers were purchased from
Invitrogen (CA, USA). Real time PCR reactions were carried out
in a MJ Mini
TM Personal Thermal Cycler apparatus (Bio-Rad
Laboratories, CA, USA). Melting curves were obtained by
increasing the temperature from 60 to 95uC with a temperature
transition rate of 0.5uC/sec. The comparative threshold cycle
number (CT) method was used to assess the relative quantification
of gene expression. The fold change of the target gene was
calculated as 2
2DD CT [18].
Determination of reactive oxygen species (ROS)
Fluorimetric determination of intracellular ROS generated by
adherent cells was performed in a 24-well plate after loading with
29,79-dichlorodihydrofluorescein diacetate (DCHF-DA) (Molecu-
lar Probes, Invitrogen, Paisley, UK), as previously described [19].
The intracellular ROS content was also measured by flow
cytometry (Cyan). Harvested cells were incubated with 5 mM
DCHF-DA for 20 min in the dark at 37uC, washed and re-
suspended in PBS. For each sample, 10.000 events were acquired
and intracellular ROS formation was detected as a result of the
oxidation of DCHF at a wavelength of 520 nm. Data analysis was
carried out with the Summit software.
Superoxide anion release was estimated by means of the
superoxide dismutase-inhibitable cytocrome c reduction, as
previously described [20]. Briefly, 15610
3 cells/well were plated
in 24-well plates and incubated in Krebs-Ringer phosphate buffer
with glucose (145 mM NaCl, 4.8 mM KCl, 0.5 mM CaCl2,
1.2 mM MgSO4, 5.7 mM NaPO4, 5.5 mM glucose [pH 7.4])
(KRPG) containing 80 mM ferricytochrome c (type III; Sigma),
with or without SOD (final concentration 300 units/ml), in a total
volume of 1 ml. After incubation for 1 h at 37uC, the reaction was
Fibroblast Phenotype in IPF
PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e14003stopped by placing the culture supernatants in melting ice, and the
absorbance was read at 550 nm in a Sclavo Reader SR400
spectrophotometer (Siena, Italy). An extinction coefficient of
21610
3 M
21cm
21 was used for oxidized versus reduced cyto-
chrome c.
Western blot
Harvested cells were lysed in RIPA buffer (50 mM Tris-HCl
pH 7.5, 150 mM NaCl, 1% NP40, 0.5% deoxycholate,0.1%
sodium-dodecyl-sulfate, SDS) containing 2.5 mM Na-pyrophos-
phate, 1 mM b-glycerophosphate, 1 mM NaVO4, 1 mM NaF and
a cocktail of protease inhibitors (Roche Diagnostic GmbH,
Mannheim, Germany) for 30 min at 4uC. Cell lysates were
centrifuged at 13.000 rpm for 10 min at 4uC and the concentra-
tion of cellular proteins was determined using the Bio-Rad assay
(Bio-Rad). Cell proteins (20–30 mg) were mixed with a Laemmli
buffer, separated on 12% SDS-PAGE, transferred onto a
nitrocellulose membrane (Protan, Whatman GmbH, Dassel,
Germany) and hybridized with the following antibodies according
to the manufacturer’s instructions: mouse anti-a-smooth muscle
actin (SMA) mAb (1:500; Sigma), mouse anti-TGF-b mAb (1:500;
BD Pharmingen, New Jersey, US), mouse anti-p-ERK-1/2 mAb
(1:1000; Santa Cruz Biotechnology, Santa Cruz, CA, USA), and
mouse anti-phosphotyrosine (p-Tyr) mAb (1:1000; Upstate, Lake
Placid, NY, USA). Membranes were incubated with an horserad-
ish peroxidase-conjugated anti-mouse secondary antibody (1:2000;
Amersham Pharmacia Biotech) and protein bands were revealed
with the enhanced chemiluminescence (ECL) system detection kit
(Roche). Immune-reactive bands were quantified by means of
densitometry and normalized by mouse anti a-tubulin (1:3000;
Cell Signalling Technologies, Boston, MA, USA) mAb.
Statistical analysis
Results are expressed as mean 6 standard deviation (SD). All
comparisons were made on a head-to head basis using the paired
or unpaired t test, where appropriate. One way repeated measures
Figure 1. IPF Fibroblasts Display a Pro-Fibrotic Phenotype. The baseline phenotype of control (n=4) and IPF cell lines (n=7) grown in
complete medium was analyzed at different culture passages. Cell lysates from sub-confluent cultures were immune-blotted with anti-a-SMA
antibodies. Panel A shows a representative western blot of a-SMA (upper) and tubulin (lower) proteins in control and IPF fibroblasts at early and late
passages. Relative statistics for early (full bars) and late (dashed bars) passage cells are also reported. *p,0.05 versus early passage control cells;
**p,0.05 versus early passage IPF cells. Panel B shows real time PCR expression levels of type-I collagen mRNA in control and IPF fibroblasts at early
(full bars) and late (dashed bars) culture passages. *p,0.001 versus early passage control cells; **p,0.001 versus early passage IPF cells. Panel C
shows the proliferation rate of early (full bars) and late (dashed bars) passage control and IPF fibroblasts. *p,0.001 versus early passage control cells;
**p,0.001 versus early passage IPF cells. Data are expressed as mean fold change 6 SD. Late passage control and IPF fibroblasts stained for
senescence associated b-galactosidase activity are shown in panel D (magnification 10X). Arrows show b-galactosidase positive blue cells. The mean
percentage of b-galactosidase positive cells 6 SD in late passage cells (dashed bars) is reported.
doi:10.1371/journal.pone.0014003.g001
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appropriate. A p value less than 0.05 was considered statistically
significant. All analyses were performed with the GraphPad Prism
3 software package (GraphPad Software, San Diego, CA, USA).
Results
IPF Cells Display a Pro-Fibrotic Phenotype
To characterize the phenotype of IPF cells we measured the
expression of the myofibroblast differentiation marker, a-SMA,
and of type-I collagen. Expression of both molecules was increased
in early passage IPF cells compared with control fibroblasts
(Figure 1, A–B). Alpha-SMA expression increased in control and
IPF fibroblasts with time in culture (Figure 1A), while that of type-I
collagen was markedly reduced in late passage IPF cells and
decreased further in control fibroblasts (Figure 1B). Proliferation of
IPF cells, measured as DNA synthesis, was significantly less
vigorous than that of control cells at early passages (Figure 1C).
Proliferation significantly slowed down with time in culture in both
cell types. However, expression of the senescence marker b-
galactosidase was only barely detectable in both cell types with no
substantial differences even at late passages (Figure 1D). Finally, to
address whether the IPF phenotype was sustained by the ability of
cells to produce growth factors, i.e. TGF-b, acting in an autocrine
loop, a-SMA expression was analysed in early passage control
fibroblasts conditioned for 48 h with the complete medium from
control or IPF cell cultures. TGF-b is a pleiotropic cytokine that
plays a crucial role in a wide array of processes, including wound
Figure 2. The IPF Phenotype is not Dependent upon the Autocrine Influence of TGF-beta. Early passage control fibroblasts (n=3) were
cultured in the presence of medium obtained from control or IPF cell cultures for 48 h. Panel A shows a representative western blot of a-SMA (upper)
and tubulin (lower) proteins and relative statistics of three independent experiments. Representative immune-blots for TGF-b1 in cell extracts and
culture media of early passage control and IPF fibroblasts are shown in panel B. Culture media were concentrated by means of centrifugal filter
devices YM-10 (Centricon, Millipore). In the middle, 5 ng of rhTGF-b1 has been loaded as positive control. Panel C shows real time PCR expression
levels of TGF-b mRNA in control (n=4) and IPF fibroblasts (n=7) at early (full bars) and late (dashed bars) culture passages. Early passage IPF
fibroblasts (n=3) were treated for 30 min with a specific TGF-b receptor ALK5 inhibitor (10 mM) and changes of a-SMA expression were assessed at
the protein level. Representative immune-blots for a-SMA/tubulin expression and relative statistics are reported in panel D. All data are expressed as
mean fold change 6 SD.
doi:10.1371/journal.pone.0014003.g002
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an inactive molecule which becomes activated after tissue injury.
There is evidence that, among others, the integrin-mediated
activation of TGF-b is pivotal in IPF pathogenesis [21]. As shown
in Figure 2A, no significant differences in a-SMA expression
occurred in the culture conditions used. These findings were not
unexpected as integrin-mediated mechanisms were unlikely to
have occurred in our experimental setting. Further, TGF-b
protein levels were undetectable in both cell extracts and culture
media from early passage control and IPF fibroblasts (Figure 2B).
Also, no differences of TGF-b expression were appreciated at the
mRNA level in control and IPF cells, both at early and at late
passages (Figure 2C). Finally, sensitivity of early passage IPF
fibroblasts to specific TGF-b receptor inhibition was assessed. As
shown in Figure 2D, a-SMA expression was unchanged as
compared to basal levels.
These data indicate that early passage IPF cells differ from
control fibroblasts as: 1. are differentiated into myofibroblasts; 2.
have a pro-fibrotic phenotype; and 3. proliferate less. Such a
phenotype is not dependent upon the expression of growth factors,
and especially of TGF-b, acting in an autocrine manner. Both cell
types markedly slow down growth over time. This occurs along
with myofibroblast differentiation with no evidence of ongoing
senescence.
Oxidative Stress Induces and Maintains the Phenotype of
IPF Fibroblasts
To investigate whether the phenotype of IPF cells was linked to
oxidative stress we measured the expression of a-SMA and type-I
collagen in control fibroblasts upon long-term challenge with
H2O2. As shown in Figure 3A, a-SMA expression was robustly
induced by H2O2 in a dose-dependent manner at 48 h. Time-
course curves performed with a fixed concentration of H2O2
(200 mM) showed that induction of a-SMA expression increased
over time, reaching the peak between 24 and 48 h (Figure 3B).
Exposure to oxidative stress also accounted for higher expression
Figure 3. Chronic Oxidative Stress Induces a Pro-Fibrotic Phenotype. Changes of a-SMA expression were investigated by means of western
blot in early control fibroblasts (n=3) upon exogenous administration of hydrogen peroxide. Panel A shows changes of a-SMA expression upon cell
treatment with increasing concentrations of H2O2 for 48 h. Conversely, panel B shows changes of a-SMA by treating cells with a fixed concentration
of H2O2 (200 mM) at different time points. A representative immune-blot of a-SMA/tubulin is also shown. Panel C shows type-I collagen expression,
assessed by real time PCR, in cells incubated for 48 h in the presence of H2O2 (200 mM). Expression of a-SMA in H2O2 (200 mM)-treated early passage
IPF fibroblasts (n=3) over time is shown in panel D. All data are expressed as mean fold change 6 SD and are representative of three independent
experiments. *p,0.001 versus basal; **p,0.05 versus basal.
doi:10.1371/journal.pone.0014003.g003
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was negligible, ranging from 8 to 13%. Conversely, as shown in
Figure 3D, no further increase of a-SMA expression was
appreciated in H2O2-treated early passage IPF fibroblasts. Short
term incubation (15 min) with increasing concentrations of H2O2
induced death of early passage control fibroblasts in a dose-
dependent manner (Figure 4A). Similarly, control cells death also
occurred in response to a fixed concentration of H2O2 in a time-
dependent manner (Figure 4B). Conversely, early passage IPF cells
were resistant to peroxide-induced cell death in both culture
conditions (Figure 4, panels A–B). IPF cells also retained their
resistance to oxidative-induced cell death at later passages, as
shown in Figure 4 (C–D). Finally, to test whether the IPF
phenotype was sensitive to anti-oxidants, control and IPF
fibroblasts were treated for 48 h with the ROS scavenger NAC
(5 mM). Figure 5 (A–B) shows that levels of a-SMA were not
modified in control fibroblasts while significantly decreased upon
treatment in IPF cells at early passages. This finding was associated
with a concomitant reduction of type-I collagen expression in IPF
fibroblasts (Figure 5C). Conversely, no changes in a-SMA and
collagen expression occurred in NAC-exposed IPF cells at late
passages (Figure 5, panels D–E).
These data indicate that: 1. ROS stimulate normal fibroblasts to
differentiate into type-I collagen expressing myofibroblasts; 2.
conversely, ROS scavenging inhibits a-SMA and type-I collagen
expression in IPF cells; and 3. myofibroblast differentiation of IPF
cells confers resistance to oxidative stress-induced cell death.
IPF Fibroblasts Are Characterized by High ROS Levels
To dissect the nature of the signal(s) that characterizes the IPF
phenotype, we measured the spontaneous ability of IPF and
control fibroblasts to generate ROS. Mean basal ROS levels were
significantly higher in early passage IPF fibroblasts compared with
control cells, while no significant differences were recorded at late
culture passages (Figure 6A). Flow cytometry analysis showed that
early passage IPF fibroblasts were distributed as a cluster of highly
fluorescent ROS-expressing cells (Figure 6B). Conversely, the
distribution of fluorescent control cells analysed at the same
culture passages was diffuse and heterogeneous. With time in
culture the distribution pattern of ROS-expressing IPF cells
became diffuse in a wider range of fluorescence similarly to control
fibroblasts. To confirm the higher ability of IPF fibroblasts to
generate ROS we measured the levels of superoxide anion
released. Early passage IPF fibroblasts expressed higher superox-
ide anion levels compared with control cells (Figure 6C). No
differences in superoxide anion release were found at late passages.
These data indicate that early passage IPF fibroblasts: 1. express
high levels of ROS and superoxide anion in comparison with
control cells; and 2. are undistinguishable from control cells with
respect to ROS generation at late passages.
Figure 4. IPF Fibroblasts are Resistant to Acute Oxidative Stress-Induced Cell Death. Induction of cell death upon exogenous oxidative
stress was assessed by means of flow cytometry in early and late passage control (n=3) and IPF (n=3) cells. Panels A and C show the distribution of
the mean percentages of PI-positive cells treated for 15 min with increasing concentration of H2O2, in early and late passage cells, respectively. Panels
B and D show the distribution of the mean percentages of PI-positive cells treated with a fixed H2O2 concentration (1 mM) at different time points in
early and late passage cells, respectively. All data are expressed as mean percentage 6 SD of fluorescent cells and are representative of three
independent experiments. *p,0.05 versus control cells.
doi:10.1371/journal.pone.0014003.g004
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Activation of a Membrane NADPH Oxidase-Like System
To strengthen these observations we sought to identify the
source of ROS. It is known that ROS activate MEK and ERK1/2
through the inhibition of tyrosine phosphatases [22,23]: thus,
ERK phosphorylation is inducible by ROS and ROS-induced p-
ERK levels are sensitive to treatment with anti-oxidants or oxidase
inhibitors. Basal levels of p-ERK were analysed in control and IPF
fibroblasts at different culture passages. Then, since NADPH
oxidase is the main source of O2
- in most cell types [24], changes
of p-ERK expression were also analysed in response to cell
treatment with the membrane NADPH oxidase inhibitor, DPI. As
shown in Figure 7A, basal p-ERK expression was significantly
higher in early passage IPF cells in comparison with the control
ones. In addition, p-ERK levels significantly decreased in IPF
fibroblasts in response to DPI. Conversely, control cells were
insensitive to oxidase inhibition. No differences of p-ERK
expression were detectable in control and IPF cells at late passages
(Figure 7B). Similarly to control fibroblasts, IPF cells also became
insensitive to DPI treatment. To further strengthen these
observations, modulation of p-ERK levels upon H2O2 exposure
was assessed in early passage control fibroblasts. As shown in
Figure 7C, ERK phosphorylation was inducible in a dose
dependent manner by H2O2 and this effect was inhibited by
pre-treating cells with the ROS scavenger, NAC. Conversely, no
further increase of p-ERK levels was detectable in response to
H2O2 in early passage IPF cells that however were sensitive to
NAC (Figure 7D). Finally, to address whether a-SMA expression
was dependent upon ERK activation, modulation of peroxide-
induced a-SMA expression was analysed in control fibroblasts pre-
treated with the MEK kinase inhibitor UO126 (10 mM). As shown
in Figure 7E, a-SMA was induced in response to H2O2 while was
significantly decreased in UO126 pre-treated cells. Similarly, a-
SMA expression did also decrease in IPF cells upon UO126
treatment.
These data indicate that IPF fibroblasts: 1. display an active
NADPH-oxidase like system accounting for ROS formation; 2.
contain active ERK1/2 which is an exquisite sensor of the
activation status of such a system, and 3. a-SMA expression is
maintained by ROS generation through ERK activation.
Figure 5. Negative Modulation of the Pro-Fibrotic Phenotype by ROS Scavenging. Control and IPF fibroblasts were treated for 48 h with
the ROS scavenger NAC (5 mM). Panels A and B show representative immune-blots for a-SMA/tubulin and relative statistics in early passage control
(n=3) and IPF (n=3) cells, respectively. Panel C illustrates changes of type-I collagen expression in early passage IPF fibroblasts. Changes of a-SMA
and type-I collagen expression in NAC-treated late passage IPF fibroblasts (n=3) are shown in panels D and E, respectively. Data are expressed as
mean fold change 6 SD and are representative of three independent experiments. *p,0.05 versus basal.
doi:10.1371/journal.pone.0014003.g005
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PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e14003Tyrosine Kinase(s) Signalling is Constitutively Activated in
IPF Fibroblasts
NADPH oxidase may be activated by a wide array of receptors
for growth factors,includingreceptor tyrosine kinase(s) (RTKs) [25–
27]. In addition, NADPH-generated ROS can themselves sustain
signalling of RTKs through the inhibition of tyrosine phosphatases
[22]. To test this issue, we asked whether ROS rise in IPF cells was
associated with activation of tyrosine kinase(s) signalling. Figure 8A
shows that IPF cells displayed higher basal levels of tyrosine
phosphorylated proteins than control cells. Levels of tyrosine
phosphorylation were decreased in IPF cells at late passages
(Figure 8A). Tyrosine phosphorylation was inducible by H2O2 in
control fibroblasts and this effect was inhibited by pre-treatment of
cellswiththeROSscavengerNAC(Figure8B).Inasimilarmanner,
p-tyrosine levels also decreased in NAC treated IPF fibroblasts
(Figure 8B). These findings are relevant as corroborate previous
data indicating that switch-off of RTKs may have a beneficial effect
in IPF through the inhibition of myofibroblast differentiation [28–
30]. To address whether this was the case in our setting, we
measured a-SMA expression in IPF cells upon inhibition of RTKs.
Although we did not analyse the specific receptor involved,
inhibition of RTKs was associated with a marked reduction of a-
SMA levels in IPF cells. Conversely, a-SMA expression remained
unchanged in control fibroblasts (Figure 8C). However, peroxide-
induced a-SMA expression was sensitive to RTKs inhibition in
control fibroblasts as shown in Figure 8D.
In conclusion, these observations suggest that tyrosine kinase(s)
signalling: 1. is constitutively activated in IPF cells; 2. is inducible
upon oxidative stress while, conversely, is inhibited by anti-
oxidants; and 3. is required for myofibroblast differentiation.
Discussion
Fibroblasts and myofibroblasts are key effectors in wound
healing and are thought to be crucial players in IPF pathogenesis
through an unabated continuation of the repair process after the
Figure 6. IPF Cells Produce High Levels of ROS. The baseline ability of control (n=4) and IPF (n=7) cells to generate ROS was measured at
different culture passages with different methods. The intracellular content of ROS was first measured fluorimetrically in DCHF-DA loaded cells at
early passages. Panel A shows levels of DCF fluorescence in early (full bars) and late (dashed bars) passage control and IPF cells. *p,0.05 versus
control cells. Representative flow cytometry dot plots of the distribution of DCF fluorescence in control and IPF fibroblasts at different culture
passages are shown in panel B. Panel C shows O2
- production, estimated by means of superoxide dismutase-inhibitable cytocrome c reduction,
respectively in early (full bars) and late (dashed bars) passage control and IPF fibroblasts. All data are reported as mean value 6 SD and are
representative of three independent experiments. *p,0.01 versus early passage control cells; **p,0.05 versus early passage control cells; ***p,0.001
versus early passage IPF cells.
doi:10.1371/journal.pone.0014003.g006
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functions, including proliferation, apoptosis, migration and
differentiation [31,32], all crucial events to tissue homeostasis
and remodelling. Although ROS have been implicated in IPF
pathogenesis, there is no conclusive evidence linking ROS
metabolism to the phenotype of fibroblasts derived from IPF
patients. To dissect the mechanism(s) underlying the disease, we
first characterized the baseline phenotype of primary lung
fibroblasts of IPF patients. Then, we focused on the redox state
of IPF fibroblasts and investigated whether IPF features were
influenced by oxidative stress. We found that, unlike control
fibroblasts that predominantly showed a proliferative pattern,
IFP cells were differentiated into myofibroblasts and displayed a
pro-fibrotic phenotype. Previous studies have reported contrasting
proliferative characteristics of human ‘‘fibrotic’’ fibroblasts
[33,34]. In our setting, IPF cells proliferated significantly less than
control fibroblasts since the earliest culture passages corresponding
to the first 20–25 PD. However, along with time in culture
differences were no more appreciated as proliferation of IPF and
control cells drastically slowed down. The absence of visible signs
of senescence (b-galactosidase) which instead was associated with
an increased a-SMA expression in both cell types over time in
culture suggests that the progressive growth slow down was
dependent on accelerated differentiation rather than on senes-
cence [35]. IPF cells also displayed an increased ability to express
higher levels of collagen expression than control fibroblasts at early
passages. It is noteworthy that acquisition of the myofibroblast
phenotype is necessary for collagen expression and that this effect
Figure 7. ROS Generation in IPF Fibroblasts Occurs Through the Activation of a Membrane NADPH Oxidase-Like System. Basal levels
of ERK phosphorylation were assessed in control (n=4) and IPF (n=7) fibroblasts at different culture passages. Further, to determine whether a
functional NADPH oxidase complex was involved in the generation of ROS, changes of p-ERK expression were analysed in response to treatment with
DPI (20 mM), a flovoprotein inhibitor. Modulation of p-ERK levels was analysed upon 30 min of cell treatment. Representative immune-blots of p-ERK/
tubulin and relative statistics are respectively shown in panels A and B. *p,0.001 versus basal control cells; **p,0.001 versus basal IPF cells. To
investigate whether ERK signalling was inducible upon oxidative stress, early passage control (n=3) and IPF fibroblasts (n=3) were treated with
increasing concentrations of H2O2 for 30 min. Pre-treatment of cells with the ROS scavenger NAC (10 mM for 1 h) was also analysed. Representative
immune-blots and relative statistics of three independent experiments are reported in panels C (*p,0.01 versus basal; **p,0.01 versus 1 mM H2O2
treated cells) and D (*p,0.05 versus basal; **p,0.01 versus basal). To address whether ERK activation is necessary for a-SMA expression, modulation
of peroxide-induced a-SMA (H2O2 200 mM for 2 h) was analysed in early passage control cells (n=3) pre-treated with UO126 (10 mM for 30 min).
Similarly, a-SMA expression was evaluated in early passage IPF fibroblasts (n=3) in response to UO126. Panel E shows representative immune-blots of
a-SMA/tubulin and relative statistics. All data are expressed as mean fold change 6 SD. *p,0.05 versus H2O2 treated cells; **p,0.05 versus basal.
doi:10.1371/journal.pone.0014003.g007
Fibroblast Phenotype in IPF
PLoS ONE | www.plosone.org 9 November 2010 | Volume 5 | Issue 11 | e14003is persistent and irreversible even after the removal of the inducing
factor [36]. However, in our setting this ability was lost along with
culture passages suggesting that the effect of the triggering factor
was diluted out over time thus leading to the establishment of a
quiescent phenotype.
In line with previous observations [37], IPF fibroblasts were
committed to generate high ROS levels, and clustering of ROS-
forming cells accounted for an increased amount of oxidants per
cell. Interestingly, also the ability to produce ROS was lost with
time in culture, as late passage IPF fibroblasts became undistin-
guishable from control cells. Altogether, these findings clearly
suggest that IPF fibroblasts have a definitive functional lifespan
and identify a precise temporal window to appreciate the
differences between IPF and control fibroblasts.
As previously reported in skin fibroblasts obtained from systemic
sclerosis patients [20], ROS generation in IPF fibroblasts occurred
through the activation of a NADPH-like oxidase system. Indeed,
levels of active ERK, which is an exquisite sensor of intracellular
ROS rise, were susceptible to oxidase inhibition [19]. It has been
recently shown that NADPH oxidase generation of H2O2 is
required for TGF-b mediated fibrogenesis in a murine model of
lung fibrosis and similar data have also been confirmed in human
fibroblasts in vitro [38,39]. In agreement with these observations we
found that exogenous hydrogen peroxide strongly induced control
fibroblasts to differentiate into type-I collagen expressing myofi-
broblasts. In addition, exposure to oxidative stress also accounted
for activation of tyrosine kinase(s) signalling suggesting the
existence of a link between such a pathway and cell differentiation.
Figure 8. Constitutive Activation of Receptor Tyrosine Kinases in IPF Cells is Necessary for Differentiation into Myofibroblasts.
Baseline levels of p-tyrosine proteins were assessed by western blotting in early and late passage control (n=4) and IPF (n=7) cells. Representative
immune-blots are shown in panel A. Then, to address whether p-tyrosine signalling was inducible upon exogenous oxidative stress early passage
control fibroblasts (n=3) were treated for 15 min with increasing concentration of H2O2. Pre-treatment of cells with the ROS scavenger NAC (10 mM
for 1 h) was also analysed. Modulation of p-tyrosine levels are shown in a representative immune-blot in panel B (left). Conversely, representative
changes of p-tyrosine levels in early passage IPF cells (n=3) treated with NAC (10 mM for 1 h) are shown on the right. To investigate whether
myofibroblast differentiation is dependent upon tyrosine kinase signalling, changes of a-SMA expression were assessed by means of western blotting
in early passage control (n=3) and IPF (n=5) fibroblasts treated for 30 min with the RTKs inhibitors AG1296 (anti-PDGF-R, 2 mM) and AG1478 (anti-
EGF-R, 2 mM). Representative immune-blots of a-SMA/tubulin and relative statistics are shown in panel C. *p,0.001 versus untreated IPF; **p,0.01
versus untreated IPF. Finally, to investigate whether RTKs inhibition abrogates peroxide-induced a-SMA expression early passage control cells (n=3)
were pre-treated for 30 min with the RTKs inhibitors AG1296 (2 mM) and AG1478 (2 mM) and then exposed for 2 h to H2O2 (200 mM). Panel D shows
representative immune-blots of a-SMA/tubulin and relative statistics. Results are expressed as mean fold change 6 SD and are representative of three
independent experiments. *p,0.05 versus basal; **p,0.001 versus H2O2 treated cells.
doi:10.1371/journal.pone.0014003.g008
Fibroblast Phenotype in IPF
PLoS ONE | www.plosone.org 10 November 2010 | Volume 5 | Issue 11 | e14003It is likely that the NADPH-related ROS rise in IPF cells derives
from the constitutive activation of a wide array of receptors for
growth factors, also including RTKs [25–27]. Although we did not
look at the activation status of a specific tyrosine kinase receptor,
we found that tyrosine kinase(s) signalling was activated in IPF cells
and that RTKs activity was necessary for the maintenance of the
IPF phenotype. There is evidence that in the presence of high
ROS levels [19,40] several receptors may be stabilized allowing
cells to become more sensitive to sub-threshold concentrations of
growth factors and cytokines. This sets on a circuitry linking
growth factor receptors, including RTKs, NADPH oxidase and
ROS, which self-maintains and propagates locally the inflamma-
tory focus [19]. Far from being multiple discrete lesions, recent
evidence suggests FF as a complex non-malignant reactive process
responsive to local environmental stimuli. The formation of a
fibroblast reticulum is consistent with a ‘‘wave’’ of fibrosis starting
from the pleura and progressing through the lung parenchyma
[41]. In this context, we suggest that the auto-amplificatory loop
(RTKs, NADPH, ROS-pERK1/2) may be operating in the
fibroblast reticulum where the progression of a ‘‘wave of
oxidation’’ promotes through the freely ROS diffusion both cell
to cell communication and myofibroblast differentiation.
In conclusion, the present study highlights the existence of a
baseline distinctive molecular IPF phenotype characterized by an
imbalanced redox state which self maintains in culture apart from
the involvement of any triggering growth factor either exogenously
added or acting in an autocrine manner. Although recent
evidences suggest a role of autocrine TGF-b generation in
maintaining the myofibroblastic phenotype in areas of fibrosis
[42], we did not confirm these data in our setting. This phenotype
confers resistance to oxidative stress-induced cell death, can be
induced by ROS in control fibroblasts and is inhibited by ROS
scavenging. Most importantly, the IPF trait is transient, since it is
progressively lost along with time in culture. We suggest this
measurable phenotype of IPF as an assay amenable for
investigating the molecular signal(s) that initiate the events we
described and for testing and validation of target specific therapies.
It remains to be seen the site and the nature of the primary IPF
trigger.
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